COVID-19 Research Timeline
Jul 8, 2020
![Picture](assets/img/plus.png)
![](assets/upload/img/COVID/SARS-COV-2 (NIH).jpg)
China reportes a cluster of cases of pneumonia in Wuhan, Hubei Province
(Image credit: NIAID-RML)
![Picture](assets/img/plus.png)
![](assets/upload/img/COVID/49531042877_e86ca079f2_cf.jpg)
The World Health Organization issues Disease Outbreak News – Pneumonia of unknown cause
(Image credit: NIAID)
![Picture](assets/img/plus.png)
![](assets/upload/img/COVID/_DSC21031.jpg)
VIDO initiates vaccine development against the novel coronavirus
January 10, 2020![Picture](assets/img/plus.png)
![](assets/upload/img/COVID/_DSC4147.jpg)
VIDO receives permission from the Public Health Agency of Canada to work with SARS-CoV-2
News Release
![Picture](assets/img/plus.png)
![](assets/upload/img/COVID/_DSC2505.jpg)
Clinical samples received from Sunnybrook through the National Microbiology Laboratory
February 5, 2020![Picture](assets/img/plus.png)
![](assets/upload/img/COVID/VIDO (22).jpg)
SARS-CoV-2 successfully isolated in our containment level 3 facility
February 14, 2020![Picture](assets/img/plus.png)
![](assets/upload/img/COVID/DSCF07862.jpg)
Initiated development of a ferret model of COVID-19
February 24, 2020![Picture](assets/img/plus.png)
![](assets/upload/img/COVID/_DSC2264.jpg)
Dr. Falzarano and team awarded ~$1 million from the Canadian Institutes of Health Research
News Release
![Picture](assets/img/plus.png)
Immunized ferrets with two COVID-19 vaccine candidates
March 9, 2020![Picture](assets/img/plus.png)
![](assets/upload/img/COVID/March 23.jpg)
Prime Minister of Canada announces $23.3 million to support vaccine manufacturing and CL3 operations
News Release
![Picture](assets/img/plus.png)
![](assets/upload/img/COVID/VIDO (47) Gord Waldner.jpg)
Government of Saskatchewan awards $3.6 million in new funding for COVID-19 vaccine research
News Release
![Picture](assets/img/plus.png)
![](assets/upload/img/COVID/DSCF0581 (2).jpg)
Initiated development of a golden hamster model of COVID-19
April 3, 2020![Picture](assets/img/plus.png)
![](assets/upload/img/COVID/_DSC6933 (Influenza).jpg)
Government of Canada awards an additional $23 million to accelerate vaccine development
News Release
![Picture](assets/img/plus.png)
![](assets/upload/img/COVID/DSCF0584 (2).jpg)
Immunized hamsters with our COVID-19 vaccine candidate
May 14, 2020![Picture](assets/img/plus.png)
![](assets/upload/img/COVID/DSCF07862.jpg)
Pre-clinical results in ferret model demonstrates COVID-19 vaccine candidate is highly effective
News Release
![Picture](assets/img/plus.png)
![](assets/upload/img/COVID/VIDO_86A3352.jpg)
Canadian universities partner to fight COVID-19 at USask’s VIDO
News Release
![Picture](assets/img/plus.png)
![](assets/upload/img/COVID/SARS-COV-2 (NIH).jpg)
Initiated toxicology studies
(Image credit: NIAID-RML)
![Picture](assets/img/plus.png)
![](assets/upload/img/COVID/Gates.png)
Received a notice of authorization from Health Canada to initiate a Phase 1 clinical vaccine trial
News Release
![Picture](assets/img/plus.png)
![](assets/upload/img/COVID/Feb 9.png)
First volunteers vaccinated
News Release
![Picture](assets/img/plus.png)
![](assets/upload/img/COVID/Feb 9.png)
Positive Phase 1 results for COVAC-2
News Release
![Picture](assets/img/plus.png)
![](assets/upload/img/COVID/CT vaccine.png)
Clinical trials continue
COVID-19 Vaccine Trials